Neipilept®

Neupilept is a nootropic remedy effective in the treatment of cognitive disorders such as memory impairment, lack of initiative, difficulties arising from daily activities and self-care.

Active substance : Citicoline
manufactured by Sotex
Name in Cyrillic : НЕЙПИЛЕПТ

Pharmacodynamics

Citicoline is a natural endogenous compound, which is an intermediate metabolite in the synthesis of phosphatidylcholine, one of the main structural components of the cell membrane.
Citicoline has a wide spectrum of action - it helps to restore damaged cell membranes, Inhibits the effect of phospholipases, prevents excessive formation of free radicals, and also prevents the death of cells, affecting the mechanisms of apoptosis.
In an acute period of stroke, citicoline reduces the amount of damage to the brain tissue, improves the cholinergic transmission.
Citicoline reduces the duration of post-traumatic coma and the severity of neurological symptoms, in addition citicoline contributes to reducing the duration of the recovery period.
Citicoline increases the level of attention and consciousness, and reduces manifestation of amnesia
Citicoline is effective in the treatment of sensory and motor neurologic disorders of degenerative and vascular etiology.

Indications

• Acute period of ischemic stroke (as part of complex therapy)
• The recovery period of ischemic and hemorrhagic strokes
• The recovery period of ischemic and hemorrhagic strokes
• Cognitive and behavioral disorders in degenerative and cerebrovascular diseases